lobbying_activities: 1181301

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1181301	83600c6e-dee9-49fd-9d2f-4cb5c61667a0	Q4	HOLLAND & KNIGHT LLP	18466	SHIRE PHARMACEUTICALS, INC	2011	fourth_quarter	HCR	Prepare advocacy materials to be used for lobbying on issues related to development of drugs for rare diseases, reimbursement of products, and FDA review and approval of products for rare diseases and other conditions. Prepared materials regarding S. 296, Preserving Access to Life Saving Medicines Act; Met with congressional staff regarding same shortage legislation. Developed advocacy materials re: HR 3737 "Unlocking Live Saving Rare Diseases Act.	Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2012-01-03T13:32:52-05:00